Statins do not reduce risk of osteoporotic fractures, a pre-specified secondary analysis of the JUPITER trial determined. The study included 17,802 men and women with no history of atherosclerosis. The mean age was 66. During the study, 221 incident fractures occurred in the participants on rosuvastatin and 210 occurred in the placebo group. Via MedPage Today.
